The Form 144 filing by an officer signals potential insider selling. Given the small relative size (0.07% of market cap), the direct impact is limited, but it may indicate insider sentiment. Monitor for actual Form 4 filings to confirm the sale and watch for any subsequent insider selling patterns.
Price Chart
Executive Summary
Aurora Daljit Singh, an officer of Neumora Therapeutics, filed a Form 144 notice of intent to sell 146,706 shares of common stock, with an approximate market value of $220,135. The shares were acquired through the exercise of employee stock options and vesting of restricted stock units. This filing signals the insider's intent to sell, though the sale may not be executed.
Key Facts
- Officer Aurora Daljit Singh filed Form 144 to sell 146,706 shares.
- Estimated market value of the proposed sale is $220,135.
- Shares were acquired through exercise of employee stock options and vesting of RSUs.
- The filing date is August 17, 2026.
- The company has a market cap of $296M.
Financial Impact
Proposed sale of 146,706 shares valued at approximately $220,135, representing about 0.07% of the company's $296M market cap.
Risk Factors
- Insider selling could signal lack of confidence in near-term prospects.
- The sale may not be executed; Form 144 is only an intent to sell.
- Biotech sector volatility could amplify any negative sentiment from insider selling.
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 3 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 144 Filing (Primary) | 0001964306-26-000398 |
| Document: 0001964306-26-000398-index.html | 0001964306-26-000398 |
| Document: 0001964306-26-000398.txt | 0001964306-26-000398 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Aug 20, 2026 6w ago | 144 | $1.63 $0.6918 | ▲ +57.56% | ▲ +57.03% | $0.4999 (+69.33%) |
Aug 17, 2026 6w ago | 144 | $1.64 $0.7732 | ▲ +52.85% | ▲ +51.54% | $0.4999 (+69.52%) |
Aug 14, 2026 7w ago | 8-K | $1.60 $0.9994 | ▼ −37.54% | ▼ −35.55% | $0.4999 (−68.76%) |
Aug 14, 2026 7w ago | Press Release | $1.60 $0.9994 | ▼ −37.54% | ▼ −35.55% | $0.4999 (−68.76%) |
Jul 27, 2026 9w ago | 8-K | $1.66 $1.53 | ▼ −8.13% | ▼ −11.43% | $0.4999 (−69.89%) |
Jul 27, 2026 9w ago | Press Release | $1.66 $1.53 | ▼ −8.13% | ▼ −11.43% | $0.4999 (−69.89%) |
Jun 15, 2026 15w ago | 8-K | $0.9145 $1.60 | ▼ −74.96% | ▼ −75.71% | $0.4999 (+45.34%) |
Apr 17, 2026 24w ago | DEFA14A | $2.19 $1.77 | ▼ −19.18% | ▼ −23.38% | $0.4999 (−77.17%) |
Mar 30, 2026 26w ago | Press Release | $1.93 $2.25 | ▲ +16.58% | ▲ +3.98% | $0.4999 (−74.10%) |
Mar 16, 2026 28w ago | Press Release | $2.87 $2.03 | ▼ −29.27% | ▼ −33.05% | $0.4999 (−82.58%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access